Bioprognos

Wilmington, Delaware, United States

Diagnostics Cancer Biomarker Monitoring Cardiovascular Disease

Bioprognos is a spin-off of the Hospital Clínic of Barcelona (Barcelona, Catalonia), that seeks to improve clinical outcomes and quality of life for cancer ―as well as other conditions patients (with cardiovascular, neurological or endocrine disorders)―, by developing innovative, non-invasive, accurate, and cost-effective diagnostics solutions that give patients, doctors and payers the information they need from biomarkers found in a simple blood test (as well as urine and other body fluids).

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Bioprognos on @MedStartr Today #CardiovascularDisease #NeurologicalDisorders #EndocrineDisorders #Diagnostics #Cancer #BiomarkerMonitoring #MedMo #MedStartrVentures

https://www.medstartr.ai/s/RjIF3es4bHo

Get Involved in Bioprognos

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2016
Website: www.bioprognos.com/

Disease Areas

Cardiovascular Disease Neurological Disorders Endocrine Disorders

Technologies

Non-Invasive DiagnosticsDiagnostic PlatformsBiomarkersIn Vitro Diagnostics

🌐Website

What do you think of Bioprognos?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.